Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Fluticasone Treatment Report
What is Fluticasone?

Fluticasone is a corticosteroid that is available as an inhalant for the treatment of asthma, in a nasal spray for allergic and non-allergic rhinitis and in a topical cream for inflammation and itching associated with dermatitis. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Nasal congestion 3 1
Other 2 3
Allergies 2 0
Seasonal allergies 2 0
Sinus problems 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
4 100%

Dosages

  0.05 mcg daily 0.05 mg/inh daily 0.2 mg daily 2 daily 50 mcg daily 110 mcg daily 125 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Fluticasone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
1 50% Doctor's advice: 50%
Side effects too severe
1 50% Side effects too severe: 50%
Other
1 50% Other: 50%

See all 2 patients who’ve stopped taking Fluticasone

Currently Taking Fluticasone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
2
2

Stopped Taking Fluticasone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 25%
Usually
2 50%
Sometimes
1 25%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 25%
A little
1 25%
Not at all
2 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
3 75%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.